Treatment Patterns and Characteristics of Patients Prescribed Opdivo Qvantig | MicrobiomeTrials← Back to trialsNCT07636863
Treatment Patterns and Characteristics of Patients Prescribed Opdivo Qvantig
CompletedOBSERVATIONAL
Trial Details
Start: 2025-08-21Est. Completion: 2025-12-22
Enrollment target: 200 participants Locations- Florida Cancer Specialists & Research Institute, Fort Myers, Florida, United States
Other microbiome trials you might be interested in
Lung Cancer Screening
This is an optimization pathway for lung cancer screening programs. Enrolled programs will undergo an audit for elements…
Jackson, United StatesEst. completion Jun 1, 2027
PTCLNK T-Cell Lymphoma
This is a randomized, open-label, multicenter Phase III study evaluating the efficacy and safety of TR115, an EZH2 inhib…
Beijin, ChinaEst. completion Jul 30, 2029
Recruiting
EGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor
This is a study for people with locally advanced or metastatic cancer for whom previous treatment was not successful. Ad…
Seoul, South KoreaEst. completion Jun 2027